Acadia Pharmaceuticals Inc
ACAD· Nasdaq
ACADAcadia Pharmaceuticals Inc
Released Nov 6, 2018, after the close
10-Q filed Nov 6, 2018, 37 days after period end · 0001564590-18-027431
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $58.31M | $35.58M | $5.27M | $39.00K |
| Net Income | -$62.14M | -$65.25M | -$71.61M | -$38.91M |
| EPS Diluted |
Acadia Pharmaceuticals Inc · CIK 1070494 · Engraved from SEC EDGAR
| -$0.50 |
| -$0.53 |
| -$0.61 |
| -$0.39 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
